Cofttek, China s Largest Manufacturer of PEA, Draws Attention of Investors
LUOHE CITY, China, Feb 14, 2021 - (ACN Newswire) - Cofttek Holding Limited, a Chinese pharmaceutical manufacturer, has recently drawn the attention of investors, following the U.S. introduction of the FDA drug ultramicronized Palmitoylethanolamide (PEA) for COVID-19 patients. Cofttek is China s largest manufacturer of ultramicronized Palmitoylethanolamide (PEA) raw materials. Following the U.S. news, orders at Cofttek have surged, and production capacity has been saturated.
Cofttek founder Dr. Zeng explained, Following this FDA news, the share price of FSD Pharma (NASDAQ: HUGE), our main competitor in the USA, roared from $3 to $14 in a few days. As the largest PEA manufacturer in China, Cofttek has attracted similar attention from many investors in the industry.
®/Jadenu
®, BGJ398, TKI258 (dovitinib) and PDR001. Most recently, he led the development teams to achieve accelerated approval of Tabrecta
® and Zykadia
® in sickle cell disease, all under the US FDA breakthrough therapy designation. We are honored to have Dr. Shi joining the Transcenta team, said Dr. Xueming Qian, Co-Founder and CEO of Transcenta. As a seasoned biopharmaceutical industrial expert, Dr. Shi worked extensively in the areas of clinical development, translational medicine, biomarker development, and discovery research in several well-known companies. He will lead our global clinical development and registration of all therapeutic area products. The biopharmaceutical industry has made great progress in China in recent years, said Dr. Shi. As an integrated biopharmaceutical company focusing on innovative biological products, Transcenta has great potential. I m very excited to join the company and look forward to accelerating the research and development o
NUR-SULTAN, Kazakhstan – The Caspian Pipeline Consortium (CPC) marine terminal loaded 4,120,449 gross tons (32,668,264 barrels) of crude oil in 41 tankers, the press service of CPC said.
“Of 4,120,449 tons lifted in January 2021, 1,716,955 tons of crude was from the Tengiz field, 993,792 tons fro
The strategic cooperation agreement has been approved by the LGHL board of directors.
BriefingWire.com, 2/09/2021 - Early-Stage NASDAQ Listed Fintech Holdings Company looks like it has Plenty of Room for Share Price Appreciation.
All-in-One Financial Trading Platform Focused on Chinese Investors.
Wide Spectrum of Trading Options for Affluent Clients via High Tech Apps.
New Acquisition of Fintech Trading Group Crypto Asset Licensed in Dubai serving the Middle East.
Highly Experienced Management and Cooperative Partners.
In January UP Fintech Holding Limited (NASDAQ: TIGR) also known as Tiger Brokers, climbed over 98% with little news from the company. However, this gain may be reflective of new awareness for the emerging value in Fintech oriented companies by market investors.
Huize Holding Limited Announces Changes to Board of Directors
February 09, 2021 04:00 ET | Source: Huize Holding Limited Huize Holding Limited Shenzhen, CHINA
SHENZHEN, China, Feb. 09, 2021 (GLOBE NEWSWIRE) Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading independent online long-term life and health insurance product and service platform for new generation consumers in China, today announced the appointment of Mr. Aaron Xiaolei Hou to Huize’s board of directors, effective on February 12, 2021. Mr. Hou will also serve as a member of the audit committee of the board, a member of the compensation committee of the board, and a member of the nominating and corporate governance committee of the board. Mr. Li Jiang, the Company’s Chief Operating Officer, will step down from his position as a director of the Company, effective from the same date, following which the majority of Huize